Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By boosting these https://lexiezyrp425295.post-blogs.com/57010677/tirzepatide-a-promising-new-treatment-for-obesity